B-Vitamin Supplement Can Treat Psoriasis, a Skin Condition with No Cure
Pantethine shows promise in easing psoriasis, sparking headlines across health and mainstream outlets.
Evidence dossier
Intelligence passport
Measured timeline
What happened
- Velocity & Diffusion: Coverage exploded across 4 distinct news outlets with 4 published articles, achieving a live velocity of 2.
- Primary Driver: Pantethine shows promise in easing psoriasis, sparking headlines across health and mainstream outlets.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
A recent small human trial found that pantethine, a B‑vitamin derivative, eases psoriasis symptoms. The Killeen Daily Herald reported the study, while Genetic Engineering and Biotechnology News detailed the trial results.
Following the initial report, multiple outlets amplified the findings, noting the low‑cost 31‑pence pill and its potential impact on millions suffering from psoriasis. The story now sits at the intersection of medical research and public hope, though the trial remains limited in size and further validation is required.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (80% supported) Updated 56m ago.
Who reported it (4)
-
Study finds supplement eases common skin conditionThe Killeen Daily Herald · 1d ago
-
Vitamin Derivative Pantethine Alleviates Psoriasis Symptoms in Small Human TrialGenetic Engineering and Biotechnology News · 1d ago
-
-
B-Vitamin Supplement Can Treat Psoriasis, a Skin Condition with No CureGood News Network · 1d ago
Questions people are asking
What supplement was tested for psoriasis?
The supplement tested was pantethine, a derivative of B‑vitamins.
What condition is the supplement intended to treat?
It is intended to treat psoriasis, a common skin condition with no known cure.
How large was the human trial mentioned?
The trial was described as a small human trial; specific participant numbers were not disclosed.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.
Topics
Related trends
Single dose of fast-acting psychedelic nasal spray shows promise for stubborn depression
A single dose of a toad‑venom nasal spray cuts depression symptoms in early trials, sparking global health interest.
Simple exercise done just once a week could help lower blood pressure
A two‑minute weekly wall hold is sparking global health headlines as a potential shortcut to lower high blood pressure.
Nose Spray Made From Toad Venom Compound Quickly Eases Depression For Weeks in Clinical Trial
A single dose of psychedelic nasal spray has shown promise in easing stubborn depression for weeks.
Millions of people high blood pressure pills daily, now scientists are testing a small device that stimul
Millions rely on pills for hypertension while a tiny ear‑clip device sparks debate over a drug‑free alternative
What to eat for younger-looking skin
Foods that may support healthy skin are gaining attention for their potential to promote a younger-looking complexion.
A precision T-cell therapy stalls treatment-resistant cancers in clinical trial
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Open prediction lab
Can you beat the machine?
Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.
📬 The daily trend digest
The world's top trends, once a day. No spam, one-click unsubscribe.